CytomX Therapeutics, Inc. (CTMX) – Watch List Oversold stock

On Thursday, Sep 13, Shares of CytomX Therapeutics, Inc. (CTMX) were valued at $19.51 and moved 2.79% as of a recent closing trade. A total volume of 0.47 million shares were traded versus to average volume of 0.44 million shares.


CytomX Therapeutics, Inc. (CTMX) held 45.03 million outstanding shares currently. The company have shares float of 43.92 million. Now have a look at past performance (weekly performance to year to date performance) how CytomX Therapeutics, Inc. (CTMX) has been moved; whether it performed well or not. CTMX reported a change of -3.27% over the last week and performed -13.52% over the last month while its year to date (YTD) performance revealed an activity trend of -7.58%. The stock’s quarterly performance specifies a shift of -22.27%, and its last twelve month performance is stands at 17.53% while moved -42.79% for the past six months.

Twenty-day SMA is useful at identifying swing trading trends lasting twenty days. Shorter moving average timeframes are more sensitive to price fluctuations and can pick up on trend changes more quickly than longer-term moving averages. However, these more frequent signals may also result in more “whipsaws”, resulting in erroneous trade signals. CTMX recently closed with fall of -11.77% to its twenty-Day SMA. This short time frame picture represents a downward movement of current price over average price of last twenty days.

52 week High and Low

CytomX Therapeutics, Inc. (CTMX) shares have been seen trading -44.26% off its 52 week- peak value and changed 19.99% from its 52 week-bottom price value. The “percentage off the 52-week high or low” refers to when a stock current price is relative to where it has traded over the last 52 weeks. This gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range.

Analysts recommendation for CytomX Therapeutics, Inc. (CTMX)

Analysts have suggested a mean rating of 1.60 on the shares. This is based on a 1-5 numeric scale where Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell.

Relative Strength Index (RSI)

CytomX Therapeutics, Inc. (CTMX)’s Relative Strength Index (RSI) is 29.59. RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. Average True Range (14) for CytomX Therapeutics, Inc. (CTMX) is stands at 1.15. ATR is a volatility indicator. Volatility measures the strength of the price action, and is often overlooked for clues on market direction.

Over the past week, the company showed volatility of 6.63%. Moving out to look at the previous month volatility move, the stock is at 4.72%.


Kenneth Wysocki covers the Services Sector of He has over 5 years experience writing services and business news. He is a graduate of the University of Florida graduating with an MBA. He focuses on adding value to shareholders' portfolios via thoroughly checked proprietary information and data sources. He has a very strong interest in stock trading, and other various investments. He presently lives in Fort Myers, FL with his wife Heidi.

Leave a Reply

Your email address will not be published. Required fields are marked *